Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Intermittent fasting may increase the risk of muscle loss, digestive issues, and energy crashes
The i has New weight loss jab gold rush offers obesity hope to millions
A nivel de tejido adiposo, la contribucin del agonismo GIP y GLP-1 reduce la infiltracin de macrfagos M1 y de citoquinas proinflamatorias como leptina, aumenta la adiponectina e incrementa la insulinosensibilidad, mejorando la disfuncin adipocitaria39
Although GLP-1 medications have transformed obesity treatment, there remains a significant need for rigorous data examining how these therapies affect fertility and reproductive function in this population. The RESTORE study is currently evaluating semaglutide treatment in girls and women with PMOS and obesity, with the overarching goal of determining whether weight loss and metabolic improvements can restore ovulation and improve reproductive outcomes
